戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              RACE (Rapid Amplification of cDNA Ends) identified a 1.5
2                                              RACE (rapid amplification of cDNA ends) PCR is useful fo
3                                              RACE analysis extended the sequence and identified this
4                                              RACE and RT-PCR identified a splice variant of FKBP8 lac
5                                              RACE describes all alveoli that visibly change volume wi
6                                              RACE experiments then mapped the 3' terminus of the upst
7                                              RACE is 55-330 times faster and 2-5 times more accurate
8                                              RACE is easy to use, as it requires adjustment of only t
9                                              RACE mapping revealed that lpiA/acvB were co-transcribed
10                                              RACE processed these terabyte-sized datasets on a single
11                                              RACE was used to identify one major and two minor transc
12                                              RACE-RepSeq VJ full-length sequencing additionally revea
13                                           3' RACE provided evidence for variability in the 3' UTR due
14             Real-time PCR and 5' RACE and 3' RACE experiments revealed that this locus encodes two tr
15 for the QQS mRNA was identified by 5' and 3' RACE experiments.
16  were obtained by assembling their 5' and 3' RACE polymerase chain reaction products.
17 hain reaction (RT-PCR) followed by 5' and 3' RACE showed that Sh-NOS is a protein of 1,517 amino acid
18 lable immunoglobulin sequences and 5' and 3' RACE to clone and sequence heavy and light chain immunog
19 some 2 were designed, and, through 5' and 3' RACE, clones from 506 genes were sequenced and cDNA sequ
20 nce, reverse transcription-PCR and 5' and 3' RACE.
21 bout 6 kb through conventional RT-PCR and 3' RACE.
22 gene structures were delineated by 5' and 3' RACE.
23 and polyadenylation sites were defined by 3' RACE.
24                                        In 3' RACE, the poly(A) tail functions as a non-specific tag a
25 o nt 7299 or 7307, respectively, by using 3' RACE.
26   Examination of mGL50 cDNA transcripts by 3'RACE revealed an alternatively spliced form, mGL50-B, th
27                                      Using 3'RACE, we confirmed expression of two distinct forms of t
28                         In addition, using 3'RACE, we identified three previously unknown mGlu1 recep
29                                    5'-and 3'-RACE experiments have subsequently identified a 900-bp c
30                                   5'- and 3'-RACE experiments identified a total of 11 R. reniformis
31 T47D breast carcinoma cells by RT-PCR and 3'-RACE PCR and identified a novel extended form of QSOX1 t
32 e use of these conditions yielded 5'- and 3'-RACE products that were approximately 80% GC over 213 an
33  108-158 nt) through genomic analysis and 3'-RACE technique, which was confirmed by RNA blot analysis
34  As an initial step, we performed 5'- and 3'-RACE with SULT1C1 cDNA.
35 ed and verified using RPE/choroid 5'- and 3'-RACE.
36 uence of MIH, in conjunction with 5'- and 3'-RACE.
37  RNA-sequencing data, followed by 5'- and 3'-RACE.
38 ctive polyadenylation sites identified by 3'-RACE are conserved in human, mouse, and chicken SCN8A.
39  from the one for UT-A2 and identified by 3'-RACE new transcripts of UT-A1, UT-A2, and UT-A3, charact
40 5'-methylguanosine-capped RNA followed by 3'-RACE sequencing.
41  amplification of complementary DNA ends (3'-RACE) polymerase chain reaction, we identified a chimeri
42                             We used 5'-or 3'-RACE, GenomeWalking, reverse transcriptase polymerase ch
43                                Subsequent 3'-RACE, 5'-RACE and high fidelity PCR were then used to pr
44 d RNA-Seq procedures, as well as a 1200 bp 5 RACE product coupled with PACBio sequencing that can ide
45                                           5' RACE analysis revealed the presence of a previously unde
46                                           5' RACE analysis revealed the presence of the transcription
47                                           5' RACE analysis was performed to determine the functional
48                                           5' RACE analysis, promoter-reporter assays, and semiquantit
49                                           5' RACE carried out with CWR22Rv1 and HepG2 cells detected
50                                           5' RACE indicates a transcription start site for HYDIN2 out
51                                           5' RACE studies localized the initiation sites to a <100 bp
52 l clones in mediating tumor regression, a 5' RACE technique was used to determine the distribution of
53                         Real-time PCR and 5' RACE and 3' RACE experiments revealed that this locus en
54 validation using RNA cleavage assays, and 5' RACE identified the prooncogenic basic helix-loop-helix
55  that gene was then cloned by both 3' and 5' RACE.
56 ' end of the K12 transcript was mapped by 5' RACE (rapid amplification of cDNA ends) and S1 nuclease
57 ranscription start site was identified by 5' RACE (rapid amplification of complementary DNA ends).
58 criptional start sites were determined by 5' RACE analysis.
59 y and late transcripts were identified by 5' RACE and primer walking techniques.
60 ha were mapped within the third intron by 5' RACE and S1 nuclease protection.
61 transcript initiation sites identified by 5' RACE is located 159 nucleotides upstream of the putative
62 onic promoter of miR-9-5 was validated by 5' RACE PCR.
63 ptional initiation site was identified by 5' RACE techniques using total RNA from NIH 3T3 cells.
64 This was followed by sequencing of cloned 5' RACE products and of products re-amplified from excised
65                               We employed 5' RACE to isolate the 5' end of the fusion transcript and
66 ed by rapid amplification of 5' cDNA end (5' RACE), RT-PCR analysis and genome sequence analyses.
67 r to rapid amplification of 5' cDNA ends (5' RACE) for HIV-1 RNA and quantitative reverse transcripta
68  and 5' rapid amplification of cDNA ends (5' RACE) to be located 25 nt upstream of the ATG in exon 1.
69                  The classical scheme for 5' RACE described here is simple, suffices in many instance
70 led with library screening and a modified 5' RACE-PCR strategy, resulted in the identification and ch
71 ys, and independently with inverse PCR of 5' RACE clones, common mRNA initiation sites were identifie
72                               By means of 5' RACE cloning methodology, a novel putative full-length h
73                   The 3000 BP upstream of 5' RACE product were subcloned into a pGL3 luciferase repor
74                Interestingly, analysis of 5' RACE products for antisense transcripts and the GenBank
75                 The approach was based on 5' RACE with [32P]-labelled primers and separation of produ
76 genomic structure of BMPR1A, we performed 5' RACE from lymphoblastoid cell lines and normal colon tis
77                              We performed 5' RACE on mRNA isolated from murine chondroprogenitor cell
78 le in mediating tumor regression and that 5' RACE analysis may provide an important tool for the anal
79                                       The 5' RACE analysis of the human testis mRNA revealed the exis
80 f the sequence variation defined from the 5' RACE products.
81                          Results from the 5' RACE-PCR methods were consistent among themselves but di
82  with yeast or human DBR1 enzyme prior to 5' RACE and qRT-PCR.
83 rt sites of 69 rpoH-dependent genes using 5' RACE (5' rapid amplification of cDNA ends), which allowe
84                                     Using 5' RACE (rapid amplification of cDNA ends) analysis, multip
85 rame (ORF) of 3.5 kb was elucidated using 5' RACE and genomic sequence.
86 e 5' end of the murine Rad51l2 cDNA using 5' RACE technique as well as by sequencing the genomic regi
87 MS1 proximal promoter, initially by using 5' RACE to map transcription start sites.
88                                     Using 5' RACE we have now identified a novel BCL-X non-coding exo
89                                     Using 5' RACE, two transcription initiation sites were identified
90                                     Using 5' RACE, we have isolated four additional exons of the mu o
91                                     Using 5' RACE, we identified three promoters, designated A, B and
92                                     Using 5' RACE, we identified three transcription start sites and
93 rt sites in human MTHFR were mapped using 5' RACE.
94                                          5' -RACE and primer extension identified a long 5' -untransl
95                                            5'RACE followed by functional promoter analysis in multipl
96 cer-testis Ag NY-ESO-1 were cloned using a 5'RACE method from RNA isolated from a CTL generated by in
97                          Bioinformatic and 5'RACE (rapid amplification of cDNA ends) analyses of the
98                                 RT-PCR and 5'RACE experiments confirm the presence of four additional
99                  The results of RT-PCR and 5'RACE suggest that only PRB is inactivated, although PRA
100  results obtained using global RNA-Seq and 5'RACE.
101                                 We applied 5'RACE and a deep sequencing-based approach to investigate
102 H1 and vnfH transcriptional start sites by 5'RACE (5' rapid amplification of cDNA ends) revealed that
103 DNA sequence analysis of cDNA generated by 5'RACE from CSF1R coding sequences identified a novel fusi
104 ' rapid amplification of cDNA ends method (5'RACE), and immunohistochemical staining.
105   Rapid amplification of 5'-cDNA ends-PCR (5'RACE-PCR) revealed at least three novel forms of the unt
106 o alternative promoter was observed by RLM-5'RACE PCR and reverse transcriptase PCR analyses during e
107  amplification of 5' cDNA ends by PCR (RLM-5'RACE PCR) analysis of C. cellulovorans RNA identified a
108     Additionally, sequence analysis of the 5'RACE-PCR products revealed multiple transcriptional star
109                                      Using 5'RACE, we demonstrate that Giardia promoters are a source
110  in vitro DNA-binding assays combined with 5'RACE, that BrlR binds to its own promoter, likely via a
111                                           5'-RACE (rapid amplification of cDNA ends) data indicate th
112                                           5'-RACE analysis defined transcript start sites for sbi, ef
113                                           5'-RACE analysis of mouse embryo cDNA targeting five candid
114                                           5'-RACE identified p53 mRNA transcribed from a novel start
115                                           5'-RACE mapped the transcription start site for one of the
116 d several alternative splice sites with a 5'-RACE approach.
117 rmed by RNA-Sequencing, and extended by a 5'-RACE assay and Northern blotting, showing that meiotic c
118                                         A 5'-RACE study determined the transcriptional start site of
119                  This prompted additional 5'-RACE experiments that established a second, TATA box-con
120                     Database analysis and 5'-RACE (rapid amplification of cDNA ends) identified a 419
121                                RT-PCR and 5'-RACE analysis revealed that cdr and bb0729 are co-transc
122 ive RT-PCR and used for Northern blot and 5'-RACE analysis.
123 scripts produced from the dnaK operon and 5'-RACE mapped 5' termini of multiple dnaK transcripts with
124                                RT-PCR and 5'-RACE mapping showed that the 5' UTR has a length of 1.94
125 ere cloned from a skin library by 3'- and 5'-RACE reactions.
126                cDNA library screening and 5'-RACE revealed that the major transcript encoded an open-
127 ning strategy (RT-PCR followed by 3'- and 5'-RACE) to clone from Y-organs of the blue crab (Callinect
128                          Using RT-PCR and 5'-RACE, we observed that following transcriptional activat
129 enes by using a combination of RT-PCR and 5'-RACE.
130  cleavage of a subset of these targets by 5'-RACE analysis.
131 anscriptional start of human CRLR cDNA by 5'-RACE and cloned the proximal 5'-flanking region of the g
132 by comparing the repertoires generated by 5'-RACE PCR and multiplex PCR.
133 tes of all three genes were determined by 5'-RACE revealing large leader sequences for each transcrip
134 d associated promoter (P1), was mapped by 5'-RACE to a region 19 kb upstream of the ZFP106 translatio
135 nt upstream of the ATG initiation site by 5'-RACE.
136      Rapid amplification of 5'-cDNA ends (5'-RACE) analysis demonstrated exclusive use of the CBS -1b
137      5'-rapid amplification of cDNA ends (5'-RACE) and computational analyses were used to identify c
138      Rapid amplification of 5'-cDNA ends (5'-RACE) and reverse transcription-PCR assays identified sh
139  and 5'-rapid amplification of cDNA ends (5'-RACE) revealed five major ADAR1 transcriptional start si
140         Rapid amplification of cDNA ends (5'-RACE) was used to isolate the CDT6 promoter from an adap
141 cs analysis, rapid analysis of cDNA ends (5'-RACE), and reverse transcription coupled with qPCR using
142 ing 5' random amplification of cDNA ends (5'-RACE), and the binding sites for purified HlyU were disc
143 ing rapid amplification of the cDNA ends (5'-RACE), we identified one transcription start site (TSS).
144 entary deoxyribonucleic acid (cDNA) ends (5'-RACE).
145 ngest 5'-untranslated region derived from 5'-RACE and apparently generated by the distal promoter has
146   Here we report the isolation by genomic 5'-RACE PCR and in vitro analysis of the mouse PIASgamma pr
147 oth endothelial cells and liver; however, 5'-RACE analysis (rapid amplification of cDNA ends) identif
148          We obtained evidence by modified 5'-RACE for a MYB mRNA cleavage product guided by miR828 in
149 RNA, whose cleavage was shown by modified 5'-RACE.
150 question, we conducted deep sequencing of 5'-RACE products of the Igh repertoire in pro-B cells, ampl
151 he neuronal channel SCN8A, we carried out 5'-RACE (rapid amplification of cDNA ends) with RNA from hu
152                         We also performed 5'-RACE experiments on 62 novel regions, and 76% of the reg
153                       Subsequent 3'-RACE, 5'-RACE and high fidelity PCR were then used to produce a f
154 eight were further confirmed with the RLM 5'-RACE experiments.
155 uently full-length cDNA was cloned by the 5'-RACE (rapid amplification of cDNA ends) technique and se
156                                       The 5'-RACE analysis of RARbeta2 mRNA in these cells demonstrat
157 , both the RNase protection assay and the 5'-RACE assay detected endogenous pim-1 transcripts with sh
158 d" antibody repertoires by sequencing the 5'-RACE PCR products of B-cell transcripts from IAVI donor
159                                  By using 5'-RACE, alignment of EST sequences, and a luciferase-repor
160 o be mediated by an RNAi mechanism, using 5'-RACE.
161 s in vitro and murine enterocytes in vivo.5'-RACE identified two novel exons, 1A and 1B, which encode
162                     Using Primer walking, 5'-RACE PCR and in silico analyses, we characterized nine J
163  EST libraries for OSC fragments to use in a RACE PCR-based approach and cloned three full-length OSC
164                                   Additional RACE and Northern analysis revealed that at least five d
165 end-polymerase chain reaction amplification (RACE-PCR).
166  Reverse transcription-PCR amplification and RACE were used to acquire the former menthone:(-)-(3R)-m
167  Reverse transcription-PCR amplification and RACE were used to acquire the remaining 5'-sequence from
168  which 6 were confirmed by northern blot and RACE.
169         This work demonstrates Raman-DIP and RACE are effective culture-independent approach for rapi
170 was obtained and verified through RT-PCR and RACE (rapid amplification of cDNA ends).
171         The gene was amplified by RT-PCR and RACE of the poly(A)+RNA isolated from the mouse melanoma
172 s of this novel gene using interexon PCR and RACE technologies.
173 ction of oligonucleotide primers for PCR and RACE-derived cDNAs from which the complete sequence of f
174  novel sequences by using degenerate PCR and RACE.
175 dii Using a combination of transcriptome and RACE sequencing, we identified 33 opsin transcripts expr
176                                     We apply RACE-Seq to 398 human lncRNA genes in seven tissues, lea
177 orporating other transcriptomic data such as RACE, CAGE, and EST into its model to further increase i
178 yosuroides hydrolase (Amgdsh1) was cloned by RACE-PCR and expressed in the yeast Pichia pastoris as a
179 sequence of the DCAL-1 gene was confirmed by RACE-PCR; however, based on sequence alignment with geno
180    All corresponding cDNAs were confirmed by RACE.
181 using bioinformatic predictions, followed by RACE, RT-PCR, and sequencing.
182             We then cloned the novel gene by RACE-PCR, and analysis of the deduced cDNA sequence foun
183 ons of the mouse OR genes were identified by RACE-PCR.
184 ouse ovarian adapter-ligated cDNA library by RACE-PCR, and a unique 2043-bp open reading frame was de
185 s or siRNA and analyzed cleavage products by RACE.
186 ate Control Versus Electrical Cardioversion (RACE) trials that anticoagulation should not be disconti
187                                      Current RACE methods often produce a high background of nonspeci
188 e extremely GC-rich sequences, using current RACE methods.
189 nfarction in Carolina Emergency Departments (RACE) project, transported via emergency medical service
190                             Here we describe RACE-Seq, an experimental workflow designed to address t
191                               Many different RACE methods have been developed to meet various require
192               Raman activated cell ejection (RACE) was applied to isolate single AMR bacteria for the
193        5' Random amplification of cDNA ends (RACE) analyses identified two distinct promoters, p1 and
194         5' rapid amplification of cDNA ends (RACE) analyses of RNAs prepared from G50DblKo and wild-t
195         3'-Rapid amplification of cDNA ends (RACE) analyses of the terminated RNA products allowed pr
196         5' rapid amplification of cDNA ends (RACE) and deletion analysis were used to identify the di
197 erns using rapid amplification of cDNA ends (RACE) and full-length cDNA sequencing, revealed four ind
198 such as 5'-Rapid Amplification of cDNA Ends (RACE) and inverse polymerase chain reaction (PCR).
199 fied by 3' rapid amplification of cDNA ends (RACE) and Northern blot analyses in several EBV-positive
200 ations, 3' rapid amplification of cDNA ends (RACE) and polymerase chain reactions (PCR) were performe
201 luding the rapid amplification of cDNA ends (RACE) and tiling array technologies that was used to fur
202 ted by the rapid amplification of cDNA ends (RACE) approach.
203  5' and 3' rapid amplification of cDNA ends (RACE) experiments and findings of novel splicing events
204 ction, and rapid amplification of cDNA ends (RACE) experiments indicate the presence of multiple tran
205 m adapting rapid amplification of cDNA ends (RACE) for large-scale structural transcript annotation.
206 ies and by rapid amplification of cDNA ends (RACE) from liver, spleen and lung RNA.
207 sis and 3' rapid amplification of cDNA ends (RACE) in placenta confirmed the existence of distal intr
208            Rapid amplification of cDNA ends (RACE) is widely used to determine the 5'- and 3'-termina
209 mRNA using rapid amplification of cDNA ends (RACE) PCR as long as part of the mRNA sequence is known;
210 sults from rapid amplification of cDNA ends (RACE) PCR suggest that there are multiple transcriptiona
211 t using 5' rapid amplification of cDNA ends (RACE) PCR.
212        The rapid amplification of cDNA ends (RACE) procedure is a widely used PCR-based method to clo
213 5'- and 3'-rapid amplification of cDNA ends (RACE) product and assembling the sequences, we generated
214 5'- and 3'-Rapid Amplification of cDNA Ends (RACE) revealed IGH/CHST11 as well as CHST11/IGH fusion R
215  have used rapid amplification of cDNA ends (RACE) to identify multiple transcription initiation and
216            Rapid amplification of cDNA ends (RACE) was performed on RNA isolated from human RPE cells
217            Rapid amplification of cDNA ends (RACE) was used to obtain potentially full-length transcr
218  method of rapid amplification of cDNA ends (RACE) was used to obtain their cDNA sequences from 11 cD
219 A by 5'/3' rapid amplification of cDNA ends (RACE), 5' radiolabeling, and exonuclease digestion, whic
220 ned using random amplification of cDNA ends (RACE), and promoter regions were compared with orthologu
221 encing, 3' rapid amplification of cDNA ends (RACE), and tiled microarray analyses.
222  (RT-PCR), rapid amplification of cDNA ends (RACE), and transient expression of minigene constructs.
223 ed with 5' rapid amplification of cDNA ends (RACE), in vitro transcription assays, real-time quantita
224 etected by rapid amplification of cDNA ends (RACE), primer extension, and ribonuclease protection ass
225      Using rapid amplification of cDNA ends (RACE), reverse-transcription polymerase chain reaction (
226 , using 5' rapid amplification of cDNA ends (RACE), two transcriptional start sites (TSSs) and two pu
227   Using 3' rapid amplification of cDNA ends (RACE), we mapped the 3' end of the N and NSs mRNAs, show
228 y using 5' rapid amplification of cDNA ends (RACE), we mapped two HPV18 transcription start sites (TS
229            Rapid amplification of cDNA ends (RACE)-PCR extension of expressed sequence-tag sequences
230 solated by rapid amplification of cDNA ends (RACE).
231 loning and rapid amplification of cDNA ends (RACE).
232 scripts by rapid amplification of cDNA ends (RACE).
233 T-PCR) and rapid amplification of cDNA ends (RACE).
234 y by using rapid amplification of cDNA ends (RACE).
235 ermined by rapid amplification of cDNA ends (RACE).
236 ssed by 5' Rapid Amplification of cDNA Ends (RACE).
237 pid amplification of complementary DNA ends (RACE), chemical inhibition experiments, and genetic disr
238 pid amplification of complementary DNA ends (RACE), two transcriptional start sites were identified.
239 pid amplification of complementary DNA ends (RACE)-polymerase chain reaction (PCR) and three multiple
240 repetitive alveolar collapse and expansion" (RACE).
241 the Real-time Accurate Cell-shape Extractor (RACE), a high-throughput image analysis framework for au
242                 We describe here an improved RACE procedure using circular cDNA templates and demonst
243                 Thus, the term "collapse" in RACE refers to a visibly obvious collapse of the alveolu
244  by the development of alveolar instability (RACE) and the increase in alveolar size at peak inspirat
245                    We furthermore integrated RACE with our framework for automated cell lineaging and
246             We have used RNA ligase mediated RACE and in silico analyses to locate two sets of transc
247 tokine termed IL-17D was cloned using nested RACE PCR.
248 kine, termed IL-17F, was cloned using nested RACE PCR.
249                                         'New RACE' (rapid amplification of cDNA ends) PCR is a method
250                     Thus, we developed a new RACE method that can be used for this purpose.
251                                Although 'new RACE' can also be used to amplify 3' ends, only the prot
252                                      In 'new RACE', an anchor is ligated to the 5' end of the mRNA be
253  of effector action, the requirement for NON-RACE-SPECIFIC DISEASE RESISTANCE1 (NDR1) is shared.
254       Arabidopsis (Arabidopsis thaliana) NON-RACE-SPECIFIC DISEASE RESISTANCE1 (NDR1), a plasma membr
255                                  We obtained RACE data for approximately two-thirds of the examined t
256                         Sequence analysis of RACE products showed that the truncation is due to a sin
257             We demonstrate the generality of RACE by extracting cell-shape information from entire Dr
258                                  By means of RACE PCR, three full-length cDNAs not reported previousl
259 l workflow designed to address this based on RACE (rapid amplification of cDNA ends) and long-read RN
260 ing 5' rapid amplification of cDNA ends-PCR (RACE-PCR), and strong sigma(54) and sigma(70) consensus
261 by PCR-rapid amplification of cDNA ends (PCR-RACE).
262 diated Rapid Amplification of cDNA Ends (PPM-RACE).
263 ementary DNA ends-polymerase chain reaction (RACE-PCR) on patient RNA, rabaptin-5 was identified as a
264                               Gene reporter, RACE, and chemical inhibitor studies demonstrated that t
265  from Hydra vulgaris using 3'- and 5'- (RLM) RACE approaches.
266                      Experiments using 5'RLM-RACE demonstrated that the genes EpSPL1, 2, 3, 4, 7, 9,
267 transcriptome profiling combined with 5'-RLM-RACE analysis in transgenic plants confirmed that amiRNA
268 In the current work, we have utilized 5'-RLM-RACE to examine the influence of CGG repeat number on th
269 diated rapid amplification of cDNA ends (RLM-RACE) and RT-PCR to identify four transcription start si
270 diated rapid amplification of cDNA ends (RLM-RACE) between -61 and -32 bp from the translation initia
271 diated rapid amplification of cDNA ends (RLM-RACE) PCR analysis indicated that the single transcripti
272 diated rapid amplification of cDNA ends (RLM-RACE) reads, and 50,000 cap-trapped expressed sequence t
273 their 5' and 3' UTR were amplified using RLM-RACE.
274 e corrected proactively with our large-scale RACE platform.
275 on of cDNA ends-based repertoire sequencing [RACE-RepSeq]), we detected a lambda LC monoclonal expans
276 otting, reverse transcription-PCR, and SMART-RACE analyses suggest that the dlt transcript begins 250
277 med systematic series of pseudogene-specific RACE analyses.
278 lve altered alveolar mechanics, specifically RACE and alveolar overdistension.
279 sted gene-specific primer and the 3' or 5' T-RACE primer results in specific amplification of cDNA en
280                        Overall, we show that RACE-Seq is an effective tool to annotate an organism's
281                                          The RACE amplification technology was used on a novel CYP3A-
282                                          The RACE II (Rate Control Efficacy in Permanent Atrial Fibri
283                         The sequences of the RACE sorted cells indicate that they were potential huma
284                 In addition, high-throughput RACE successfully extended the 5' and/or 3' ends of >60%
285 sing this targeted approach, high-throughput RACE, we revealed numerous transcripts including many un
286                                        Thus, RACE-RepSeq appears as a sensitive, rapid, and specific
287  associated with the 5'-ends of at least two RACE products.
288                                        Using RACE PCR, reverse transcription-PCR (RT-PCR) and RNA-seq
289                                        Using RACE procedures, we cloned and sequenced the complete 4.
290                                        Using RACE, we automatically reconstructed cellular-resolution
291 sis of the 5'- and 3'-ends of the mRNA using RACE analysis determined that the ADH4 mRNA in C57BL/6 m
292 th cDNAs of each product were obtained using RACE-PCR.
293 nfirmed its 3' end nucleotide sequence using RACE-PCR.
294 of supporting evidence and tested them using RACE-PCR.
295 se results show that direct validation using RACE-PCR can be an important component of genome-wide va
296  simple, suffices in many instances in which RACE is needed and can be performed in 1-3 days.
297                                         With RACE, molecular cloning, and long read sequencing, we fo
298 thology, whereas lung tissue from areas with RACE mechanics demonstrated alveolar collapse, atelectas
299        RT-PCR sequencing in combination with RACE on ab initio gene predictions could be used to defi
300 ing strand-specific RT-PCR complemented with RACE and FISH.

 
Page Top